MicroRNA Deregulation in Blood Serum Identifies Multiple System Atrophy Altered Pathways

Area of Science:

• Neuroscience
• Genetics
• Biochemistry

Background:

• MicroRNA (miRNA) alterations are known in Parkinson's disease (PD).
• However, miRNA expression in Multiple System Atrophy (MSA), another α-synucleinopathy, is under-investigated.
• This study explores serum miRNA profiles in MSA.

Purpose of the Study:

• To profile genome-wide serum microRNA expression in MSA patients.
• To identify differentially expressed miRNAs in MSA compared to controls.
• To investigate if identified miRNAs can distinguish MSA from PD.

Main Methods:

• Genome-wide miRNA profiling in serum from 20 MSA cases and 40 controls.
• Quantitative PCR (qPCR) validation of top miRNAs in a separate cohort (20 MSA, 20 controls).
• Assessment of miRNA expression in PD patient cohorts (n=19 and n=18).

Main Results:

• 25 differentially expressed miRNAs were identified in MSA, linked to prion disease, fatty acid metabolism, and Notch signaling.
• Nine miRNAs were validated via qPCR in a second MSA cohort.
• MicroRNA-7641 and microRNA-191 showed consistent ability to differentiate between MSA and PD.

Conclusions:

• Serum miRNA expression changes are associated with MSA and may indicate underlying disease mechanisms.
• Specific miRNAs, miR-7641 and miR-191, show potential as biomarkers to differentiate MSA from PD.
• Further research is warranted to elucidate the role of these miRNAs in α-synucleinopathies.